ADAI News & Events
March 29, 2023
NEW: U.S. FDA Approves Narcan (4mg Naloxone Nasal Spray) for Over-The-Counter Purchase/Use
From the US FDA press release: Today, the U.S. Food and Drug Administration approved Narcan, 4 milligram (mg) naloxone hydrochloride nasal spray for over-the-counter (OTC), nonprescription, use – the first naloxone product approved for use without a prescription. Naloxone is a medication that rapidly reverses the effects of opioid overdose and is the standard treatment…
March 28, 2023
DATE CHANGE! ADAI Lunch & Learn: Addressing the Risks of High THC Cannabis (now on April 20, 12pm PT)
Join us on April 20, 2023 (12-1pm PT) for our next ADAI Lunch & Learn: Addressing the Risks of High-THC Cannabis: The Public Health and Legislative Saga Presenters: Beatriz Carlini, PhD, MPH, Sharon Garrett, MA, MPH, Lexi Nims, BA (ADAI Cannabis Education & Research Program) With cannabis commercialization has come the wide availability of new…
March 24, 2023
RECORDING AVAILABLE: Fentanyl Epidemic Townhall, March 23, 6pm (in-person & virtual)
March 23, 2023 | 6-7:30pm PT | View recordingPacific Northwest University, Butler-Haney Hall 200 University Parkway Yakima, WA 98901 Hear directly from experts in Washington State as they share their role in preventing fentanyl overdose. Drug overdose is a growing public health crisis in Yakima County. In 2021, 98 sons, daughters, wives, husbands — community members…
March 14, 2023
Virtual Tour of Syringe Services Programs, March 29 (12-1pm PT)
Join us to take a virtual tour of syringe services programs in Washington State! Wednesday, March 29th 12-1pm PT Curious what a syringe services program looks like and what they do? Here’s your chance to visit the SSPs in Tacoma, Centralia, and Walla Walla on a virtual tour of their mobile and indoor sites. Walk…
March 6, 2023
Ask an Expert: Is Mandating Treatment Necessary or Helpful?
Caleb Banta-Green, PhD, MPH, MSWDirector, UW Center for Community-Engaged Epidemiology, Education, and Research (CEDEER) Substance use-related health services are a well-researched area. Many people, however, have outdated understandings of substance use and “substance use disorder” (addiction) and also don’t know much about what truly motivates someone to seek services to reduce the harms associated with…
February 22, 2023
New ADAI Report & Virtual Tour: Overview and Perspectives of Syringe Services Programs in WA State
New ADAI Report This new report, Overview and Perspectives of Syringe Services Programs in Washington State, written by Susan Kingston of the ADAI Center for Community-Engaged Drug Education, Epidemiology and Research (CEDEER), describes how Washington State syringe services programs (SSPs) operate, the services they provide, the challenges they face, and their untapped potential. Citation: Kingston…
ADAI Lunch & Learn: Community Engaged Research with People Who Use Drugs: Lessons Learned from the READU Team (March 14, 12pm PT)
Join ADAI and presenters Jenna van Draanen, PhD, MPH and Courtney Wetterman (both of the UW School of Nursing) for our next virtual Lunch & Learn, March 14, 2023, 12-1pm PT. This presentation will cover principles and methods of community-engaged research, using an example from our research team of people with lived and living experience…
February 15, 2023
ADAI in the News: Dr. Caleb Banta-Green on Over-the-Counter Naloxone and Low-Barrier Treatment
ADAI Acting Professor Caleb Banta-Green, PhD, MPH, MSW recently talked with Scripps National News about making the opioid overdose antidote naloxone available over-the-counter (OTC). The FDA is meeting today (Feb. 15, 2023) to review the application for an OTC version of naloxone nasal spray. Though the goal of such a move would be to expand…
February 8, 2023
New from ADAI: Community Implementation of Contingency Management to Address Stimulant Use (Hartzler, 2023)
A new publication by ADAI Research Associate Professor Bryan Hartzler, PhD and colleagues reports outcomes of an interagency partnership among the Northwest ATTC, Oregon Health Authority, and Oregon Recovery and Treatment Centers, LLC. This partnership involved an intensive technical assistance project in which opioid treatment programs successfully implemented customized contingency management programming to increase stimulant abstinence…
February 6, 2023
New: How Should Policymakers Regulate the THC Content of Cannabis Products? (Opinion piece in Addiction)
Since the sale of cannabis to adults was first legalized in Colorado and Washington State in 2012, the THC content of cannabis flower has increased and so have sales of high-potency cannabis vapes, extracts, and concentrates. Increased use of higher THC cannabis products can lead to increased cannabis-related harms, including accidents, adverse psychological reactions, psychotic…
Next page
